Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges of clinical trial design for DMD.

Neuromuscular disorders : NMD - 1 Dec 2015

Ricotti Valeria, Muntoni Francesco, Voit Thomas

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to DMD gene
Share to Muscular Dystrophy, Duchenne
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26584589
DOI: 10.1016/j.nmd.2015.10.007

Genes

DMD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges of clinical trial design for DMD.PMID 26584589Read ↗

From Bench to Bedside: A Meta-Analysis of Translational Research in Duchenne Muscular DystrophySemantic proximity Read ↗

Drug development progress in duchenne muscular dystrophySemantic proximity Read ↗

Lessons for clinical trial design in Friedreich's ataxia.Semantic proximity Read ↗

New and emerging pharmacotherapy for duchenne muscular dystrophy: a focus on synthetic therapeutics.Semantic proximity Read ↗

Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’Semantic proximity Read ↗

Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical TrialsSemantic proximity Read ↗

Exploring Barriers to Clinical Trial Readiness Among the Myotonic Dystrophy Community: A Mixed-Methods StudySemantic proximity Read ↗

Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’Semantic proximity Read ↗

Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophySemantic proximity Read ↗

Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.Semantic proximity Read ↗

Myotonic dystrophy mouse models: towards rational therapy developmentSemantic proximity Read ↗

Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular DystrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.